Rare disease funds to boost pancreatic and blood cancer studies: Rare Disease Day feature

Adj A/Prof Charles Pilgrim and Prof Andrew Spencer describe

their newly funded MRFF research and how it will help patients.

Early this month Central Clinical School researchers were awarded funding under the MRFF’s 2021 Rare Cancers, Rare Diseases and Unmet Need (RCRDUN) program. 

As part of Rare Disease Day today, we asked two CCS researchers - Charles Pilgrim from the Department of Surgery, and Andrew Spencer from the Australian Centre for Blood Diseases - working with rare diseases about the research being funded.

$19.3 million for rare cancer and rare disease research

L-R: Prof Andrew Spencer (ACBD), A/Prof Trisha Peel (Infectious

Diseases) and Adj.A/Prof Charles Pilgrim (Surgery) in CCS

have won MRFF grants.

Researchers in the Faculty of Medicine, Nursing and Health Sciences will receive $19,324,213 under the 2021 Rare Cancers, Rare Diseases and Unmet Need (RCRDUN) grant opportunity.

Congratulations to the three researchers from Central Clinical School who received MRFF funding. See detail below.